Bellevue Life Sciences Acquisition (BLAC) Competitors $0.64 +0.03 (+4.10%) As of 10/6/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsOwnershipSEC FilingsTrendsBuy This Stock BLAC vs. SSKN, AMIX, LUCY, GCTK, PTHL, BBLG, NAOV, WOK, QNRX, and NDRAShould you be buying Bellevue Life Sciences Acquisition stock or one of its competitors? The main competitors of Bellevue Life Sciences Acquisition include Strata Skin Sciences (SSKN), Autonomix Medical (AMIX), Innovative Eyewear (LUCY), GlucoTrack (GCTK), Pheton (PTHL), Bone Biologics (BBLG), Nanovibronix (NAOV), WORK Medical Technology Group (WOK), Quoin Pharmaceuticals (QNRX), and ENDRA Life Sciences (NDRA). These companies are all part of the "medical equipment" industry. Bellevue Life Sciences Acquisition vs. Its Competitors Strata Skin Sciences Autonomix Medical Innovative Eyewear GlucoTrack Pheton Bone Biologics Nanovibronix WORK Medical Technology Group Quoin Pharmaceuticals ENDRA Life Sciences Strata Skin Sciences (NASDAQ:SSKN) and Bellevue Life Sciences Acquisition (NASDAQ:BLAC) are both small-cap medical equipment companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, profitability, earnings, dividends, media sentiment, valuation, risk and institutional ownership. Does the media refer more to SSKN or BLAC? In the previous week, Strata Skin Sciences had 3 more articles in the media than Bellevue Life Sciences Acquisition. MarketBeat recorded 3 mentions for Strata Skin Sciences and 0 mentions for Bellevue Life Sciences Acquisition. Strata Skin Sciences' average media sentiment score of 0.64 beat Bellevue Life Sciences Acquisition's score of 0.00 indicating that Strata Skin Sciences is being referred to more favorably in the media. Company Overall Sentiment Strata Skin Sciences Positive Bellevue Life Sciences Acquisition Neutral Which has more risk and volatility, SSKN or BLAC? Strata Skin Sciences has a beta of 0.5, indicating that its stock price is 50% less volatile than the S&P 500. Comparatively, Bellevue Life Sciences Acquisition has a beta of -0.08, indicating that its stock price is 108% less volatile than the S&P 500. Do analysts prefer SSKN or BLAC? Strata Skin Sciences presently has a consensus target price of $6.00, suggesting a potential upside of 210.88%. Given Strata Skin Sciences' stronger consensus rating and higher possible upside, equities research analysts clearly believe Strata Skin Sciences is more favorable than Bellevue Life Sciences Acquisition.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Strata Skin Sciences 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00Bellevue Life Sciences Acquisition 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Which has preferable earnings and valuation, SSKN or BLAC? Bellevue Life Sciences Acquisition has lower revenue, but higher earnings than Strata Skin Sciences. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioStrata Skin Sciences$33.56M0.24-$10.09M-$2.84-0.68Bellevue Life Sciences AcquisitionN/AN/AN/AN/AN/A Do institutionals & insiders hold more shares of SSKN or BLAC? 32.4% of Strata Skin Sciences shares are held by institutional investors. Comparatively, 55.3% of Bellevue Life Sciences Acquisition shares are held by institutional investors. 39.0% of Strata Skin Sciences shares are held by insiders. Comparatively, 33.7% of Bellevue Life Sciences Acquisition shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Is SSKN or BLAC more profitable? Bellevue Life Sciences Acquisition has a net margin of 0.00% compared to Strata Skin Sciences' net margin of -35.13%. Bellevue Life Sciences Acquisition's return on equity of 0.00% beat Strata Skin Sciences' return on equity.Company Net Margins Return on Equity Return on Assets Strata Skin Sciences-35.13% -266.94% -32.66% Bellevue Life Sciences Acquisition N/A N/A N/A SummaryStrata Skin Sciences beats Bellevue Life Sciences Acquisition on 8 of the 12 factors compared between the two stocks. Get Bellevue Life Sciences Acquisition News Delivered to You Automatically Sign up to receive the latest news and ratings for BLAC and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BLAC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BLAC vs. The Competition Export to ExcelMetricBellevue Life Sciences AcquisitionHolding Offices IndustryManufacturing SectorNASDAQ ExchangeMarket Cap$2.57M$238.05M$2.54B$10.53BDividend YieldN/A6.61%2.57%4.66%P/E RatioN/A0.1726.6726.85Price / SalesN/A468.47116.03185.94Price / CashN/A123.7047.7931.10Price / BookN/A7.5443.656.72Net IncomeN/A-$12.18M$6.99M$276.44M7 Day Performance21.53%3.15%1.36%3.13%1 Month Performance10.43%14.41%3.69%10.21%1 Year Performance-94.17%291.42%58.87%40.35% Bellevue Life Sciences Acquisition Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BLACBellevue Life Sciences AcquisitionN/A$0.64+4.1%N/A-94.4%$2.57MN/A0.00N/AGap UpHigh Trading VolumeSSKNStrata Skin Sciences2.5203 of 5 stars$2.06flat$6.00+191.3%-27.8%$8.59M$33.56M-0.73120AMIXAutonomix Medical2.8601 of 5 stars$1.17+8.3%$5.00+327.4%-90.0%$6.69MN/A-0.201Positive NewsLUCYInnovative Eyewear0.4624 of 5 stars$1.96+1.6%N/A-75.6%$6.37M$1.64M-0.719News CoverageGCTKGlucoTrack0.1541 of 5 stars$6.38-3.2%N/A-99.7%$5.93MN/A-0.115PTHLPhetonN/A$0.78+0.6%N/A-87.3%$5.12M$450K0.0011Positive NewsGap DownBBLGBone Biologics0.3205 of 5 stars$2.79flatN/A-74.4%$5.01MN/A0.002NAOVNanovibronix0.1527 of 5 stars$6.06+7.4%N/A-88.8%$4.49M$2.56M-0.4520Gap DownWOKWORK Medical Technology GroupN/A$0.08+4.1%N/A-98.3%$4.27M$11.51M0.00226Short Interest ↓QNRXQuoin Pharmaceuticals0.704 of 5 stars$7.23+0.6%N/A-56.4%$4.23MN/A-0.174Positive NewsNDRAENDRA Life Sciences1.1876 of 5 stars$5.62+4.5%$50.00+789.7%-13.9%$4.05MN/A-0.1720Positive News Related Companies and Tools Related Companies SSKN Competitors AMIX Competitors LUCY Competitors GCTK Competitors PTHL Competitors BBLG Competitors NAOV Competitors WOK Competitors QNRX Competitors NDRA Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BLAC) was last updated on 10/7/2025 by MarketBeat.com Staff From Our PartnersBitcoin grabs headlines, but smart money likes this tokenBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredThe Tiny Stock Set to Soar with Musk's AI AmbitionsThe Tiny Stock Set to Soar with Musk's AI Ambitions While Musk builds one of the most ambitious AI empires ...Behind the Markets | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | Sponsored$3,600 gold is nice ... but here’s what most gold bugs are missingGold just surged past $3,600, but Weiss Ratings expert Sean Brodrick says the real upside is in select gold st...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bellevue Life Sciences Acquisition Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bellevue Life Sciences Acquisition With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
